refid# O1NQ76k32Qr3vvd596wvOaymj7 pages
dd Dec 20 WP WP0 DE/NL Responsible WP1 DE/NL Activities Coordination Preparation of Call for Evidence (including questionnaire and information document) in agreement between MS Call for Evidence (all MS and ECHA with news alerts and websites of all MS with Link to Helpdesk webpage) Preparation of Restriction option analysis document (all MS) RIME+ Dortmund 1st draft of restriction option analysis document (all MS) 2nd draft of restriction option analysis document (all MS) Finalisation of document, i.e. clarification of restriction options and scope (all MS) Restriction option analysis document to be uploaded on CIRCA (DE/ NL CA) RMOA-Conclusion, PACT-Update WP2 Drafting discussion paper NL Wordt vragenlijst + aanvulling 1e discussion paper WP3 DE/DK DE/DK WP4 NL/DE Verwerken commentaren van NO, SE, DE, I&W en RIVM deskundigen Coordination and alignment Pre-phase for environmental and human health hazard assessment --> Overview of relevant hazards (besides persistence) and generation of draft lists of substances for assessment Assessment phase --> Draft text for restriction proposal WP5 NO WP6 SE/DE Overview analytical methods (ch E7) Overview human and environmental monitoring data Working plan Design template for collection of monitoring date Presentation of slide WP6 at RiME Meeting wieh NCSU Collect monitoring data - ENV Collect monitoring data - HUM RiME FEB-2021 WP7 Scoping essential use NL Scoping impact assessment Baseline and restriction scenario(s) Economic impact assessment Environmental impact assessment Health impact assessment Assessment of other impacts Proportionality analysis Monthly meetings starts 2nd version questionnaire Draft of information document (DE/NL CA) Commenting round (all MS) Revision and draft of 3rd version of questionnaire and information document for WebEx (DE/NL CA) Detailed discussion of questionnaire and information document (all MS) Webex Final version (DE/ NL CA) Notification into PACT (DE/ NL CA) Discussion of responses received so far, data (all MS) Webex Decision on meetings with industry (all MS) DDiescciusisosnioonnowf rheiscthrircetisotrnicstcioonpeopantidonospstihoonusld(ablleMpSre) sWenetbeedx and discussed in RiME+ (all MS) Meetings with stakeholders and industry Presentation on RMOA for RiME May 2020 Contributions of first drafts of document parts according to lead in work packages and sub-work packages (all MS) Merge of contributions, redrafting (DE/ NL CA) Redrafting by all MS Merge of contributions, redrafting (DE/ NL CA) 31-Mar-20 4-May-20 August/September 2020 20/21 October 2020 25-Sep-20 5-Oct-20 19-Oct-20 Last redrafting by all MS Finalisation (DE/ NL CA) Commenting (by all other MS not part of group) Consideration of comments/if needed redrafting of document (DE/ NL CA in agreement with group) Webex meeting for initial discussing based on broad definition (NL, DE, SE, DK, NO, ECHA, COM) 1st discussion paper prepared by NL Face-to-face meeting (NL, DE, SE, DK, NO, ECHA, COM) based on discussion paper 2nd discussion paper prepared by NL (before RiME+) 26-Oct-20 10-Nov-20 23 - 27 November 2020 1-Dec-20 4-Jan-21 Discussion during RiME+ meeting Final discussion paper prepared by NL 2021 - TO BE PREPARED Kick-off meeting Joint HH/ENV progress meetings HH subgroup meetings ENV subgroup meetings Start up, Develop generic information basis for all sub-uses, structure of the sub-use reports (by WP7) - DONE Kick-off meeting (Discussion of content of each sub-use to avoid overlaps and discussion of revision of list of sub-uses and discussion of ETH Zrich work) - DONE 1 May 2020 1 Nov. 2020 Start up sub uses, Project plan fine tuning for sub-uses (and if needed tendering for consultants) Progress meeting after CfE is closed to check sub-uses, decide on stakeholder meetings (i.e. via mail) Stakeholder Meetings per sub-use: Follow up on information from CfE and to address knowledge gaps Sub-use studies (including gap analysis) Progress meeting Progress meeting Final reports consultants (& feedback to WP2) Integration of information (including gap analysis) Additional studies (i.e. membranes, processing aids?)
refid# emLmY7aOBppOm8VvjNXq6ayg440 pages
From: To: CC: Sent: Subject: Attachments: Novae, Phil Fletcher, Steven G CIV NAVSEA HQ, SEA 05 Hunstad, Mary P CIV NAVSEA HQ, SEA 05 8/11/2016 4:11:22 PM [Non-DoD Source] Singapore Aviation Academy foam seminar FFF- Where is the Limit- JCastro, SAAJul16.pdf; Fluorine-free Fire-fighting Foam - Solberg Luc Jacobs.pdf; Interactions of Fire-fighting foam with fuel-Dynax Chang Jho.pdf; Reducing Environmental Impacts in Class B Firefighting Foams -FINAL MW presented, Singapore Jul16.pdf Steven, Thanks again for taking the time out and meeting with me last Tuesday.
refid# K6NEX464RxKX5BN3KgVM7Qw1Q1 page
GAO Review of DOD Drinking Water Contaminants (100947) Follow-up Questions on AFFF Products In our prior conversations with Navy officials, we have been told that DOD's AFFF MILSPEC calls for AFFF products to contain PFCs.
refid# DDeap2VMNnKkwrOLpYQdMKZYd1 page
From: To: Sent: Subject: Attachments: Mach, Richard CIV OASN (EI&E), ODASN (Environment) Nehm, Lindsay R CIVOPNAV, N45; Holmes, Wanda L CIV OPNAV, N45; Turner, Misha GS13 l&L, LFL; Sakai, Craig K CIV l&L, LFL; Sadorra, Robert A CIV NAVFAC HQ, EV; Brown, Kim P CIV NAVFAC HQ, EV; Coghlan, Gunarti H CIV NAVFAC HQ, EV; Lansdale, Lawrence L CIV NAVFAC HQ, BRAC PMO; McCarthy, Christine; Armel, Alaina; King, Thomas W CIV l&L; Tarker, Todd M WO AVN, APX/AVN; Pritchard, Michael CIV l&L, MCICOM G3; Adelson, Jordan M CIV SEA04X, LQAO; Williams, Scott R CIV MCI EAST; Hunstad, Mary P CIV NAVSEA HQ, SEA 05; Fletcher, Steven G CIV NAVSEA HQ, SEA 05; Berkoski, Daniel T CIV NAVSEA, SEA 05 12/12/2016 8:30:50 PM FW: GAO 100947 FOLLOW-UP DRINKING WATER GAO 100947 FOLLOW-UP QUESTIONS.docx All, I just spoke with Ophelia and suggested we have a meeting/call to discuss these, as we did at the opening for this GAO review.
refid# qgbL2KrxENzj6RQVX7knDQaM1 page
GAO Review of DOD Drinking Water Contaminants (code 100947) Follow-up Questions for the Department of the Navy Note: These questions are addressed to the Department of the Navy, to answer on behalf of both the Navy and the Marine Corps.
refid# V0Nkk8xbgw9jm2d3pRBYRKXK2 pages
ENVIRONMENTAL PHYSICAL/CHEMICAL, FATE, EFFECTS AND MONITORING STUDIES 3M MANUFACTURING FACILITIES STUDY TITLE LABORATORY OR DATE AUTHOR COMPLETED TYPE Selected Fluorochemicals in the Decatur, Alabam a Area Entrix, Inc. 06/01/01 Final Report Analysis of Alfalfa Harvested From 3M Cordova, Illinois Plant Facility 3M Environm ental lab 10/25/00 Final Report
refid# Z4X0BM2DQO37n5Okg9MYmDoxJ1 page
BAKT MAIN 3M Environmental Laboratory BaciCopyof wtaBHaHv r SJlOO M ethod D e t e r m in a t io n o f P e r fl u o r o o c t a n e SULFONATE (PFO S), P e r f l u o r o o c t a n e SULFONYLAMIDE (PFO SA ), AND PERFLUOROOCTANOATE (POAA) IN WATER BY LlQUIDSo u d E x tr a c tio n and H ig h -P e r fo r m a n c e L iq u id C h ro m a to g ra ph y /T a n d em M a ss Sp e c t r o m e t r y (H PLC/M S/M S) M ethod N um ber: ETS-8-154.0 A doption Dote: / looq A uthor: K risten J.
refid# 4Me5Vm1xr765dOyokGGMjpk117 pages
3M Environmental Laboratory IU26-002S M ethod E xtraction of Potassium Perfluorooctanesulfonate or other FLUOROCHEMICAL COMPOUNDS FROM URINE FOR ANALYSIS USING H P L C - Electrospray/M ass Spectrometry/M ass Spectrometry Method Number: ETS-8-96.0 Adoption Date: Author: Lisa Clemen, Glenn Langenburg Revision Date: /\/ j\ Approved By: Laboratory Manager v s f i f i n ------ Group Leader n l fr cluvu!
refid# 85wjkGxBBO17G4kren0xqqYLm14 pages
t\PjlS>-oxi3 Feces3MMPerMothtoEocdDoDIlCfeoAvreLSlotDpumEdyPeAnNtRoM.TTeMt-Da6Eb3eNo1ril6Tvis.a,1mtC7iv,OSeTtsRu-.6Pd2yO9fSRo.A2r1PT,eETrf-Tl7uO1o3Xr2oI.o3C;cOtSaLTnOe-4sG1ulYfonatc SFfTetlhcuuieodssrysimtnuOeedbtAyajebniscoatlldiyivteteesi:ciaganlnaCelydhsetiosm. gisetnryerTaeteamspteociumseenfsofrodretvheelo3pMmEenntvairnodnmvaelindtaatliLonabaomraetothioyd of Research O ient: 33SMMainCSt pPeenacuteilar,l,MtyBNuCihl5de5imn1gi4c42a3ls6Division Sponsor: 33SMMainCSt pPeenacuteilar,l,tMyBNuCihl5de5imn1gi4c42a3ls6Division Study Location: 33SMMainCSt tPernaautteelrg,,iMcBNTuiol5dx5iinc1go4l42o7g0y-L3Sab-0o6rartooorym SB314 Study Director: PAT33SMhMaoni.xdn: iMCrt6ceP5oewena1ldou-tMieg5clr,y7a.
refid# ev2RdnMBaaGkbXpa4dvrzEabg7 pages
7W U r r f j * 2h / Lv/ Q^x^lQ $*<e r " C J^az n z z ia m o ?
refid# Yrqxw10886KrgvynMdONe1kzO1 page
A R 226-1881 ~ D u Po(PT *~Zb z /Iizc+J IAPj>#T }/ v l g ^ T J A j ^ de^oe^ /t a ^ Amt A f li^dko^- PhoyiA.
refid# RpNaboNKnojK0QjYk9mGpEgqV2 pages
AR226-2032 m /.- i * `tpitt/*" M-' i..'
refid# 5b2wp3M9BLmNyJ5wQY6M9p61R1 page
AR226-2046 Roger J .
refid# 102nw5N3oM38BbpMNnK1bVjZd1 page
!.
refid# dYmGagXYN5LmQ3GZgwoJ11aDe1 page